+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Continuous Renal Replacement Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • ID: 4911382
  • Report
  • October 2019
  • Region: Global
  • 243 pages
  • Transparency Market Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International, Inc
  • INFOMED SA
  • Medica SPA
  • NIKKISO CO., LTD
  • MORE
Continuous Renal Replacement Therapy Market - Scope of the Report

The report on the global continuous renal replacement therapy (CRRT) market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global continuous renal replacement therapy market for the period of 2017-2027, with 2018 as the base year and 2027 as the last forecast year. The report also provides the compound annual growth rate (CAGR) for the global continuous renal replacement therapy market for the forecast period.

The report has been prepared after extensive research. Primary research involves bulk of the research efforts, wherein, analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global continuous renal replacement therapy market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approach to study various phenomena in the global continuous renal replacement therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global continuous renal replacement therapy market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global continuous renal replacement therapy market. The next section of the global CRRT market report highlights the USPs, which include a rising incidence of the acute kidney injury, growing prevalence of diabetes & hypertension, reimbursement and regulatory scenarios, globally, recent technological advancements in the global continuous renal replacement therapy market, and key mergers & acquisitions.

The report delves into the competitive landscape of the global continuous renal replacement therapy market. Key players operating in the global continuous renal replacement therapy market have been identified, and each one of them have been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global continuous renal replacement therapy market profiled in this report.

Key Questions Answered in the Continuous Renal Replacement Therapy Market Report
  • How do recent technical advancements provide scope of growth in the global continuous renal replacement therapy market?
  • How are mergers & acquisitions among players widening the scope for continuous renal replacement therapy?
  • What are the revenue share projections of key segments under various criteria in the global continuous renal replacement therapy market during the forecast period?
  • Which segment is likely to lead the continuous renal replacement therapy market in terms of revenue by 2027?
  • How are changing reimbursement and regulatory scenarios, along with changing healthcare systems in developing countries making an impact on the global CRRT market?
Research Objectives and Research Approach

The comprehensive report on the global continuous renal replacement therapy market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, and healthcare compliances laid down by accredited agencies in the purview of research in the global continuous renal replacement therapy market. It is followed by market introduction, market dynamics, and an overview of the global continuous renal replacement therapy market, which includes an analysis of the market drivers, restraints, and trends affecting the growth of the global continuous renal replacement therapy market.

Furthermore, to understand the Y-o-Y trends of the continuous renal replacement therapy market, a Y-o-Y analysis with elaborated insights on the same has been provided. The next section of the global continuous renal replacement therapy report highlights the USPs, which include technological advancements, development of CRRT systems for pediatrics, rising AKI incidences, and key industry events in the global market.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International, Inc
  • INFOMED SA
  • Medica SPA
  • NIKKISO CO., LTD
  • MORE
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Continuous Renal Replacement Therapy Market

4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Continuous Renal Replacement Therapy Market Analysis Forecast, 2017–2027
4.4.1. Market Revenue Projection (US$ Mn)

5. Market Outlook
5.1. Incidence of Acute Kidney Injury Across the Globe
5.2. Rise in Prevalence of Diabetes and Hypertension
5.3. Reimbursement Scenario by Region/globally
5.4. Regulatory Scenario by Region/globally
5.5. Recent Technological Developments in Continuous Renal Replacement Therapy
5.6. Development of CRRT System for Paediatric Patients
5.7. Key Mergers & Acquisitions

6. Global Continuous Renal Replacement Therapy Market Analysis Forecast, by Mode
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Continuous Renal Replacement Therapy Market Value (US$) Forecast, by Mode, 2017–2027
6.3.1. Slow Continuous Ultrafiltration (SCUF)
6.3.2. Continuous VenoVenous Haemofiltration (CVVHF)
6.3.3. Continuous VenoVenous Haemodialysis (CVVHD)
6.3.4. Continuous VenoVenous Haemodiafiltration (CVVHDF)
6.4. Continuous Renal Replacement Therapy Market Attractiveness, by Mode

7. Global Continuous Renal Replacement Therapy Market Analysis Forecast, by Product
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Continuous Renal Replacement Therapy Market Value Forecast, by Product, 2017–2027
7.3.1. Dialysate & Replacement Fluids
7.3.2. Disposables
7.3.2.1. Bloodline Sets
7.3.2.2. Hemofilters
7.3.2.3. Other Disposables
7.3.3. Systems
7.4. Continuous Renal Replacement Therapy Market Attractiveness, by Product

8. Global Continuous Renal Replacement Therapy Market Analysis Forecast, by Therapy
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Continuous Renal Replacement Therapy Market Value Forecast, by Therapy , 2017–2027
8.3.1. Renal
8.3.2. Non-renal
8.3.3. Combination
8.4. Continuous Renal Replacement Therapy Market Attractiveness, by Therapy

9. Global Continuous Renal Replacement Therapy Market Analysis Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Continuous Renal Replacement Therapy Market Value Forecast, by End-user , 2017–2027
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Others
9.4. Continuous Renal Replacement Therapy Market Attractiveness, by End-user

10. Global Continuous Renal Replacement Therapy Market Analysis Forecast, by Region
10.1. Key Findings
10.2. Continuous Renal Replacement Therapy Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Continuous Renal Replacement Therapy Market Attractiveness, by Country/Region

11. North America Continuous Renal Replacement Therapy Market Analysis
11.1. Introduction
11.1.1. Key Findings
11.2. North America Continuous Renal Replacement Therapy Market Value Forecast, by Mode, 2017–2027
11.2.1. Slow Continuous Ultrafiltration (SCUF)
11.2.2. Continuous Venovenous Haemofiltration (CVVHF)
11.2.3. Continuous Venovenous Haemodialysis (CVVHD)
11.2.4. Continuous Venovenous Haemodiafiltration (CVVHDF)
11.3. North America Continuous Renal Replacement Therapy Market Value Forecast, by Product, 2017–2027
11.3.1. Dialysate & Replacement Fluids
11.3.2. Disposables
11.3.2.1. Bloodline Sets
11.3.2.2. Hemofilters
11.3.2.3. Other Disposables
11.3.3. Systems
11.4. North America Continuous Renal Replacement Therapy Market Value Forecast, by Therapy , 2017–2027
11.4.1. Renal
11.4.2. Non-renal
11.4.3. Combination
11.5. North America Continuous Renal Replacement Therapy Market Value Forecast, by End-user , 2017–2027
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Others
11.6. North America Continuous Renal Replacement Therapy Market Value Forecast, by Country, 2017–2027
11.6.1. U.S.
11.6.2. Canada
11.7. North America Continuous Renal Replacement Therapy Market Attractiveness Analysis
11.7.1. By Mode
11.7.2. By Product
11.7.3. By Therapy
11.7.4. By End-user
11.7.5. By Country

12. Europe Continuous Renal Replacement Therapy Market Analysis
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Continuous Renal Replacement Therapy Market Value Forecast, by Mode, 2017–2027
12.2.1. Slow Continuous Ultrafiltration (SCUF)
12.2.2. Continuous Venovenous Haemofiltration (CVVHF)
12.2.3. Continuous Venovenous Haemodialysis (CVVHD)
12.2.4. Continuous Venovenous Haemodiafiltration (CVVHDF)
12.3. Europe Continuous Renal Replacement Therapy Market Value Forecast, by Product, 2017–2027
12.3.1. Dialysate & Replacement Fluids
12.3.2. Disposables
12.3.2.1. Bloodline Sets
12.3.2.2. Hemofilters
12.3.2.3. Other Disposables
12.3.3. Systems
12.4. Europe Continuous Renal Replacement Therapy Market Value Forecast, by Therapy , 2017–2027
12.4.1. Renal
12.4.2. Non-renal
12.4.3. Combination
12.5. Europe Continuous Renal Replacement Therapy Market Value Forecast, by End-user , 2017–2027
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Others
12.6. Europe Continuous Renal Replacement Therapy Market Value Forecast, by Country, 2017–2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Continuous Renal Replacement Therapy Market Attractiveness Analysis
12.7.1. By Mode
12.7.2. By Product
12.7.3. By Therapy
12.7.4. By End-user
12.7.5. By Country

13. Asia-Pacific Continuous Renal Replacement Therapy Market Analysis
13.1. Introduction
13.1.1. Key Findings
13.2. Asia-Pacific Continuous Renal Replacement Therapy Market Value Forecast, by Mode, 2017–2027
13.2.1. Slow Continuous Ultrafiltration (SCUF)
13.2.2. Continuous Venovenous Haemofiltration (CVVHF)
13.2.3. Continuous Venovenous Haemodialysis (CVVHD)
13.2.4. Continuous Venovenous Haemodiafiltration (CVVHDF)
13.3. Asia-Pacific Continuous Renal Replacement Therapy Market Value Forecast, by Product, 2017–2027
13.3.1. Dialysate & Replacement Fluids
13.3.2. Disposables
13.3.2.1. Bloodline Sets
13.3.2.2. Hemofilters
13.3.2.3. Other Disposables
13.3.3. Systems
13.4. Asia-Pacific Continuous Renal Replacement Therapy Market Value Forecast, by Therapy , 2017–2027
13.4.1. Renal
13.4.2. Non-renal
13.4.3. Combination
13.5. Asia-Pacific Continuous Renal Replacement Therapy Market Value Forecast, by End-user , 2017–2027
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Others
13.6. Asia-Pacific Continuous Renal Replacement Therapy Market Value Forecast, by Country, 2017–2027
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia-Pacific Continuous Renal Replacement Therapy Market Attractiveness Analysis
13.7.1. By Mode
13.7.2. By Product
13.7.3. By Therapy
13.7.4. By End-user
13.7.5. By Country

14. Latin America Continuous Renal Replacement Therapy Market Analysis
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Continuous Renal Replacement Therapy Market Value Forecast, by Mode, 2017–2027
14.2.1. Slow Continuous Ultrafiltration (SCUF)
14.2.2. Continuous Venovenous Haemofiltration (CVVHF)
14.2.3. Continuous Venovenous Haemodialysis (CVVHD)
14.2.4. Continuous Venovenous Haemodiafiltration (CVVHDF)
14.3. Latin America Continuous Renal Replacement Therapy Market Value Forecast, by Product, 2017–2027
14.3.1. Dialysate & Replacement Fluids
14.3.2. Disposables
14.3.2.1. Bloodline Sets
14.3.2.2. Hemofilters
14.3.2.3. Other Disposables
14.3.3. Systems
14.4. Latin America Continuous Renal Replacement Therapy Market Value Forecast, by Therapy , 2017–2027
14.4.1. Renal
14.4.2. Non-renal
14.4.3. Combination
14.5. Latin America Continuous Renal Replacement Therapy Market Value Forecast, by End-user , 2017–2027
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Others
14.6. Latin America Continuous Renal Replacement Therapy Market Value Forecast, by Country, 2017–2027
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Continuous Renal Replacement Therapy Market Attractiveness Analysis
14.7.1. By Mode
14.7.2. By Product
14.7.3. By Therapy
14.7.4. By End-user
14.7.5. By Country

15. Middle East & Africa Continuous Renal Replacement Therapy Market Analysis
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Continuous Renal Replacement Therapy Market Value Forecast, by Mode, 2017–2027
15.2.1. Slow Continuous Ultrafiltration (SCUF)
15.2.2. Continuous Venovenous Haemofiltration (CVVHF)
15.2.3. Continuous Venovenous Haemodialysis (CVVHD)
15.2.4. Continuous Venovenous Haemodiafiltration (CVVHDF)
15.3. Middle East & Africa Continuous Renal Replacement Therapy Market Value Forecast, by Product, 2017–2027
15.3.1. Dialysate & Replacement Fluids
15.3.2. Disposables
15.3.2.1. Bloodline Sets
15.3.2.2. Hemofilters
15.3.2.3. Other Disposables
15.3.3. Systems
15.4. Middle East & Africa Continuous Renal Replacement Therapy Market Value Forecast, by Therapy , 2017–2027
15.4.1. Renal
15.4.2. Non-renal
15.4.3. Combination
15.5. Middle East & Africa Continuous Renal Replacement Therapy Market Value Forecast, by End-user , 2017–2027
15.5.1. Hospitals
15.5.2. Clinics
15.5.3. Others
15.6. Middle East & Africa Continuous Renal Replacement Therapy Market Value Forecast, by Country, 2017–2027
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Continuous Renal Replacement Therapy Market Attractiveness Analysis
15.7.1. By Mode
15.7.2. By Product
15.7.3. By Therapy
15.7.4. By End-user
15.7.5. By Country

16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Position By Company (2018)
16.3. Company Profiles
16.3.1. Baxter International, Inc
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Strategic Overview
16.3.1.5. SWOT Analysis
16.3.2. Nipro Corporation
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Financial Overview
16.3.2.3. Product Portfolio
16.3.2.4. Strategic Overview
16.3.2.5. SWOT Analysis
16.3.3. Fresenius Medical Care AG & Co. KGaA
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Financial Overview
16.3.3.3. Product Portfolio
16.3.3.4. Strategic Overview
16.3.3.5. SWOT Analysis
16.3.4. Asahi Kasei Corporation
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Financial Overview
16.3.4.3. Product Portfolio
16.3.4.4. Strategic Overview
16.3.4.5. SWOT Analysis
16.3.5. B. Braun Melsungen AG
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Financial Overview
16.3.5.3. Product Portfolio
16.3.5.4. Strategic Overview
16.3.5.5. SWOT Analysis
16.3.6. NIKKISO CO., LTD
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Financial Overview
16.3.6.3. Product Portfolio
16.3.6.4. Strategic Overview
16.3.6.5. SWOT Analysis
16.3.7. Medica SPA
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Strategic Overview
16.3.7.4. SWOT Analysis
16.3.8. INFOMED SA
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Strategic Overview
16.3.8.4. SWOT Analysis
16.3.9. Medtronic (Bellco Società unipersonale a r.l.)
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Financial Overview
16.3.9.3. Product Portfolio
16.3.9.4. Strategic Overview
16.3.9.5. SWOT Analysis
16.3.10. Toray Medical Company Limited (Toray Industries, Inc.)
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Strategic Overview
16.3.10.4. SWOT Analysis
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Baxter International, Inc
  • Nipro Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • NIKKISO CO., LTD
  • Medica SPA
  • INFOMED SA
  • Medtronic (Bellco Società unipersonale a r.l.)
  • Toray Medical Company Limited (Toray Industries, Inc.)
Note: Product cover images may vary from those shown
Adroll
adroll